1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of vascular injury surgeries
5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
5.1.2. Restraints
5.1.2.1. High cost associated with the vascular injury treatment
5.1.3. Opportunities
5.1.3.1. Growing medical tourism in developing countries
5.1.3.2. Increasing advancement in technologies
5.1.4. Challenges
5.1.4.1. Side effects associated with vascular injury treatment
5.2. Cumulative Impact of COVID-19

6. Vascular Injury Treatment Market, by Injury
6.1. Introduction
6.2. Aneurysm & Pseudoaneurysm
6.3. Arteriovenous Fistula
6.4. Contusion or Intimal Flap
6.5. Laceration orTransection
6.6. Spasm
6.7. Thrombosis

7. Vascular Injury Treatment Market, by Treatment
7.1. Introduction
7.2. Bypass Graft
7.3. Extra Anatomic Bypass
7.4. Lateral Arteriorrhaphy or Venorrhaphy
7.5. Patch Angioplasty
7.6. Thrombectomy

8. Vascular Injury Treatment Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Center
8.3. Hospital

9. Americas Vascular Injury Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Vascular Injury Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Vascular Injury Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.2. Aplagon Oy
13.3. Apollo Hospitals Enterprise Ltd.
13.4. Becton, Dickinson, and Company
13.5. Boston Scientific Corporation
13.6. Cardinal Health, Inc.
13.7. CHSPSC, LLC
13.8. Cleveland Clinic
13.9. Heidelberg University Hospital
13.10. Humacyte, Inc.
13.11. IHH Healthcare Berhad
13.12. Massachusetts General Hospital
13.13. Mayo Clinic Health System
13.14. Mediclinic International PLC
13.15. Medtronic PLC
13.16. Mentice
13.17. Royal Berkshire NHS Foundation Trust
13.18. Teleflex Inc.
13.19. Tenet Healthcare
13.20. Universal Health Services, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2020 VS 2027 (%)
FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2027
FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION ORTRANSECTION, 2018-2027 (USD BILLION)
FIGURE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION ORTRANSECTION, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (%)
FIGURE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (USD BILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2027
FIGURE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 32. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 34. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 38. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. GLOBAL VASCULAR INJURY TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL VASCULAR INJURY TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VASCULAR INJURY TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION ORTRANSECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL VASCULAR INJURY TREATMENT MARKET: SCORES
TABLE 50. GLOBAL VASCULAR INJURY TREATMENT MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL VASCULAR INJURY TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL VASCULAR INJURY TREATMENT MARKET: RANKING
TABLE 53. GLOBAL VASCULAR INJURY TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL VASCULAR INJURY TREATMENT MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL VASCULAR INJURY TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL VASCULAR INJURY TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL VASCULAR INJURY TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL VASCULAR INJURY TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL VASCULAR INJURY TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

3M Company
Aplagon Oy
Apollo Hospitals Enterprise Ltd.
Becton, Dickinson, and Company
Boston Scientific Corporation
Cardinal Health, Inc.
CHSPSC, LLC
Cleveland Clinic
Heidelberg University Hospital
Humacyte, Inc.
IHH Healthcare Berhad
Massachusetts General Hospital
Mayo Clinic Health System
Mediclinic International PLC
Medtronic PLC
Mentice
Royal Berkshire NHS Foundation Trust
Teleflex Inc.
Tenet Healthcare
Universal Health Services, Inc.